Divergence of Protection Induced by Bacterial Products and Sepsis-Induced Immune Suppression
Open Access
- 1 August 2005
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 73 (8) , 4905-4912
- https://doi.org/10.1128/iai.73.8.4905-4912.2005
Abstract
Susceptibility to bacterial infections after a primary immune stimulation differs drastically depending on the presensitization of the innate immune system. To determine the conditions that either induce protection or enhanced susceptibility to infection with Salmonella enterica serovar Typhimurium, we pretreated mice either with tumor necrosis factor (TNF), whole killed bacteria, or sublethal cecal ligation and puncture (CLP) as a mouse model for septic peritonitis. Impaired production of the cytokines TNF, interleukin-6 (IL-6), and IL-10 was induced by these pretreatment schedules, with TNF-signaling not being essential for this effect. Injection of TNF or killed bacteria enhanced survival of mice infected subsequently with serovar Typhimurium. In contrast, sepsis such as that induced by CLP only protected from shock induced by d- galactosamine and lipopolysaccharide or by a high dose of bacteria but sensitized to a secondary bacterial infection. Such sepsis-induced enhanced susceptibility to infection was critically dependent on TNF function.Keywords
This publication has 46 references indexed in Scilit:
- Role of interferons in LPS hypersensitivityInnate Immunity, 2003
- Role of interferons in LPS hypersensitivityInnate Immunity, 2003
- Treatment of experimental sepsis-induced immunoparalysis with TNFImmunobiology, 2003
- Requirement of TNF and TNF receptor type 2 for LPS-induced protection from lethal septic peritonitisInnate Immunity, 2002
- Requirement of TNF and TNF receptor type 2 for LPS-induced protection from lethal septic peritonitisInnate Immunity, 2002
- IRAK-M Is a Negative Regulator of Toll-like Receptor SignalingCell, 2002
- Clinical Aspects: From Systemic Inflammation to 'ImmunoparalysisPublished by S. Karger AG ,1999
- Monocyte deactivation-rationale for a new therapeutic strategy in sepsisIntensive Care Medicine, 1996
- Interleukin‐12 is required for interferon‐γ production and lethality in lipopolysaccharide‐induced shock in miceEuropean Journal of Immunology, 1995
- Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice.The Journal of Experimental Medicine, 1987